Forensic · CGEM
Cullinan Therapeutics
No signals triggered in our 36-month window. Most stable large-caps look like this. The $9 report still gets you the full chronology of every filing scanned + a clean-record audit trail.
Bear case preview · free
Cullinan Therapeutics (CGEM) triggered zero algorithmic red flags across a 36-month lookback period, with no detected bankruptcies, financial restatements, exchange delistings, unexpected C-suite departures, equity dilution events, or material cyber incidents on record. The zero score reflects absence of acute distress signals rather than operational excellence, meaning the company simply avoided the specific trigger events the algorithm monitors. Material clinical trial failures, significant cash burn trajectory changes, or unexpected insider selling activity would be the most likely mechanisms to elevate risk scoring in the next 30-90 days.
↑ That's free. The $9 report goes deeper: every filing cited by accession number, 36-month chronology, what to watch next.
What we checked
✓ Red flags · 36mo
0 8-K events (bankruptcy, delisting, restatement, auditor, officer)
✓ Cyber · 12mo
0 Item 1.05 disclosures + buried-cyber scan
✓ Dilution · 24mo
0 S-3 + 424B5 filings
✓ Buried events
Item 8.01 sections classified for hidden material disclosures
$9
· one-time · emailed in under a minute
The full bear case on CGEM
Plain-English brief. Every signal cited to the exact SEC filing. 36-month chronology. What changes next.
✓ No-signals refund: if the algorithm finds zero red flags on your ticker, reply "refund" and I send the $9 back same day. No questions.
Not ready to buy? Get a free preview by email instead
We'll email you the top 3 signals on CGEM + a discount code for the full report. No subscription, no spam.
Score another ticker
Not investment advice. Every signal grounded in a specific SEC filing. Companies may respond via info@filingfirehose.com.